ArticleMedicine2020

Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer.

Hongjun Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.